Orion Biotechnology Canada Ltd
Orion Biotechnology Canada Ltd, based in Ottawa, specializes in the discovery and development of next-generation therapeutics targeting G Protein Coupled Receptors (GPCRs) for obesity and metabolic disorders. Utilizing their proprietary PROcisionX™ discovery platform, the company aims to create precision-engineered analogs of natural ligands, significantly enhancing the efficiency of drug discovery processes.
The company is advancing two promising candidates against the GPR75 receptor, both of which have shown efficacy in preclinical evaluations. Orion's integrated approach combines innovative technologies such as phage display and multiplex chemical synthesis to streamline the development of optimized therapeutic leads within a fraction of the time typically required in the industry.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
